GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Precigen Inc (NAS:PGEN) » Definitions » Shiller PE Ratio

Precigen (Precigen) Shiller PE Ratio

: (As of Today)
View and export this data going back to 2013. Start your Free Trial

Shiller PE for Stocks: The True Measure of Stock Valuation


Precigen Shiller PE Ratio Historical Data

The historical data trend for Precigen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precigen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Precigen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Biotechnology subindustry, Precigen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precigen Shiller PE Ratio Distribution

For the Biotechnology industry and Healthcare sector, Precigen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Precigen's Shiller PE Ratio falls into.



Precigen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Precigen's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Precigen's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.13/129.4194*129.4194
=-0.130

Current CPI (Dec. 2023) = 129.4194.

Precigen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.040 99.695 0.052
201406 -0.530 100.560 -0.682
201409 -0.530 100.428 -0.683
201412 0.180 99.070 0.235
201503 0.250 99.621 0.325
201506 -0.370 100.684 -0.476
201509 -0.340 100.392 -0.438
201512 -0.280 99.792 -0.363
201603 -0.550 100.470 -0.708
201606 -0.420 101.688 -0.535
201609 -0.240 101.861 -0.305
201612 -0.370 101.863 -0.470
201703 -0.260 102.862 -0.327
201706 -0.160 103.349 -0.200
201709 -0.330 104.136 -0.410
201712 -0.230 104.011 -0.286
201803 -0.360 105.290 -0.443
201806 -0.510 106.317 -0.621
201809 -0.440 106.507 -0.535
201812 -2.590 105.998 -3.162
201903 -0.400 107.251 -0.483
201906 -0.250 108.070 -0.299
201909 -0.350 108.329 -0.418
201912 -1.090 108.420 -1.301
202003 -0.350 108.902 -0.416
202006 -0.260 108.767 -0.309
202009 -0.180 109.815 -0.212
202012 -0.230 109.897 -0.271
202103 -0.090 111.754 -0.104
202106 -0.100 114.631 -0.113
202109 -0.150 115.734 -0.168
202112 -0.130 117.630 -0.143
202203 -0.100 121.301 -0.107
202206 -0.090 125.017 -0.093
202209 0.440 125.227 0.455
202212 -0.110 125.222 -0.114
202303 -0.100 127.348 -0.102
202306 -0.080 128.729 -0.080
202309 -0.080 129.860 -0.080
202312 -0.130 129.419 -0.130

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Precigen  (NAS:PGEN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Precigen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Precigen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Precigen (Precigen) Business Description

Traded in Other Exchanges
Address
20374 Seneca Meadows Parkway, Germantown, MD, USA, 20876
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
Executives
Jeffrey B Kindler director 35 E. 62ND ST, NEW YORK NY 10065
Randal J Kirk director, 10 percent owner, officer: Chief Executive Officer 1881 GROVE AVENUE, RADFORD VA 24141
Dean J Mitchell director C/O BRISTOL MYERS SQUIBB CO, 345 PARK AVE, NEW YORK NY 10164
Helen Sabzevari director, officer: President and CEO 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Rutul R Shah officer: Chief Operating Officer C/O PRECIGEN, INC., 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Harry Jr. Thomasian officer: Chief Financial Officer C/O PRECIGEN, INC., 20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876
Jeffrey Thomas Perez officer: SVP, IP Affairs 20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Donald P. Lehr officer: Chief Legal Officer 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Fred Hassan director C/O CARET GROUP,, 1100 HOLLAND DR., BOCA RATON FL 33487
Steven Frank director 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Vinita D Gupta director 20374 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Robert B Shapiro director 155 WEST BURTON PLACE, #2, CHICAGO IL 60610
Cesar L Alvarez director C/O PEDIATRIX MEDICAL GROUP, LEGAL DEPT 1301- CONCORD TERRACE, SUNRISE FL 33323
James S Turley director 9 MUIRFIELD LANE, SAINT LOUIS MO 63141
Ares Trading S.a. 10 percent owner ZONE INDUSTRIELLE DE L'OURIETTAZ, AUBONNE V8 1170

Precigen (Precigen) Headlines

From GuruFocus

Precigen Announces Closing of Public Offering of Common Stock

By PRNewswire PRNewswire 01-27-2023